Global Transplantation Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2029
Global Transplantation Market Overview:
"The Transplantation Market size is expected to be worth around US$ xx Billion by 2021 from US$ X.xx million in 2031, growing at a CAGR of X.x% during the forecast period 2021 to 2031."
Organ transplantation is a medical procedure in which an organ is removed from one body and placed in the body of a recipient, to replace a damaged or missing organ. The donor and recipient may be at the same location, or organs may be transported from a donor site to another location. The same applies to tissue transplantation.
Organ failure may occur due to a host of factors such as unhealthy dietary habits, loss of blood, serious trauma, drug abuse, poisoning, sepsis, and leukemia, among other acute diseases. The growing demand for organ transplantation as a result of organ failure, and the increasing demand for novel tissue transplantation products are primary factors that are expected to fuel revenue growth of the global transplantation market over the next 10 years.
The surging incident rates of acute diseases are resulting in a greater number of organ failures across the globe, and this additional factor is slated to further contribute to the future market growth of this industry.
Unfortunately, customary or religious beliefs, as well as the lack of awareness concerning organ donation is resulting in a shortage of organs necessary for the treatment of organ failure, and these factors may restrain revenue growth of the global transplantation market in the coming years.
Nonetheless, significant R&D investments being made by key industry players towards the development of new products and techniques is a factor that is anticipated to fuel future revenue growth of the global transplantation market in the foreseeable future.
Segmentation of the global transplantation market is as follows:
In terms of product, the tissue products segment accounted for the majority revenue share of the global transplantation market in 2019. The immunosuppressive drugs segment is slated to register the fastest rate of revenue growth over the next 10 years, due to the high usage of these to lower or prevent the rejection of post-transplant tissue or organs. The preservation solutions segment is also slated to index considerable revenue growth in the coming years.
On the basis of application type, the tissue transplantation segment accounted for the majority revenue share of this global market in 2019 and is further expected to index the fastest rate of revenue growth over the forecast period, as they’re the most common replacement procedures that are carried out across the globe. The organ transplantation segment is also slated to grow at a considerable rate over the next decade, owing to advancements in transplantation technology and the launch of novel transplant products.
With respect to end-use, the hospital's segment accounted for the highest number of revenue shares in this global market in 2019 and is expected to continue to do so in the years to come. However, the transplant centers segment is anticipated to index the highest rate of revenue growth over the next 10 years, due to the increasing number of healthcare centers catering to the unmet requirements of patients.
Regional Segmentation and Analysis:
North America accounted for the majority revenue share of the global transplantation market in 2019 and is expected to continue to do so over the next decade, due to well-developed healthcare facilities and the large presence of industry players in this region. However, markets in the Asia Pacific are expected to register the fastest rate of revenue growth over the next 10 years, due to increasing research being undertaken on stem cells for the development of in vitro organs and tissue.
Segmentation of the Global Transplantation Market:
Segmentation by Product Type:
- Tissue products
- Immunosuppressive drugs
- Preservation solution
Segmentation by Application Type:
- Organ transplantation
- Tissue transplantation
Segmentation by End-Use:
- Transplant centers
Segmentation by Region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn
- Abbvie Inc.
- Arthrex Inc.
- Zimmer Biomet
- Medtronic PLC
- Novartis AG
- 21st Century Medicine
- BiolifeSolutions Inc.
- Teva Pharmaceuticals
- Veloxis Pharmaceutical
Request for TOC
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
Request for Customization
Don't just take our word. We are trusted by these great companies!